The apolipoprotein A-I mimetic peptide 4F prevents defects in vascular function in endotoxemic rats
Open Access
- 1 September 2010
- journal article
- Published by Elsevier BV in Journal of Lipid Research
- Vol. 51 (9), 2695-2705
- https://doi.org/10.1194/jlr.m008086
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Structure and Function of HDL MimeticsArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptideJournal of Lipid Research, 2009
- Apolipoprotein A-I mimetic peptide treatment inhibits inflammatory responses and improves survival in septic ratsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Vasculoprotective Effects of Apolipoprotein Mimetic Peptides: An Evolving Paradigm in HDL TherapyVascular Disease Prevention, 2009
- Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patientsJournal of Lipid Research, 2008
- Inhibition of Lipopolysaccharide-Induced Inflammatory Responses by an Apolipoprotein AI Mimetic PeptideCirculation Research, 2005
- Apolipoproteins modulate the inflammatory response to lipopolysaccharideInnate Immunity, 2005
- Lipoprotein metabolism in patients with severe sepsisCritical Care Medicine, 2003
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003
- Cyclooxygenase-2 Inhibition Attenuates Lipopolysaccharide-Induced Cardiovascular FailureHypertension, 2002